Status Quo of Hybrid Coronary Revascularization for Multi-Vessel Coronary Artery Disease Ralf E. Harskamp, MD, Zhe Zheng, MD, PhD, John H. Alexander, MD, MHS, Judson B. Williams, MD, MHS, Ying Xian, MD, PHD, Michael E. Halkos, MD, J. Matthew Brennan, MD, MPH, Robbert J. de Winter, MD, PhD, Peter K. Smith, MD, Renato D. Lopes, MD, PhD The Annals of Thoracic Surgery Volume 96, Issue 6, Pages 2268-2277 (December 2013) DOI: 10.1016/j.athoracsur.2013.07.093 Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Rates of vein graft failure with 1-year angiography and restenosis and stent thrombosis rates in drug-eluting stents [7–12, 66]. The Annals of Thoracic Surgery 2013 96, 2268-2277DOI: (10.1016/j.athoracsur.2013.07.093) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 In-hospital cost-specific data of the average patient after 1-stage hybrid coronary revascularization (HCR) versus complete revascularization with off-pump coronary artery bypass graft surgery (OPCAB). The Annals of Thoracic Surgery 2013 96, 2268-2277DOI: (10.1016/j.athoracsur.2013.07.093) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions